Log in to save to my catalogue

Emerging Medical Treatments for Meningioma in the Molecular Era

Emerging Medical Treatments for Meningioma in the Molecular Era

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ae69b31270eb455eb0dae3caaa691ed6

Emerging Medical Treatments for Meningioma in the Molecular Era

About this item

Full title

Emerging Medical Treatments for Meningioma in the Molecular Era

Publisher

Switzerland: MDPI AG

Journal title

Biomedicines, 2018-08, Vol.6 (3), p.86

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Meningiomas are the most common type of primary central nervous system tumors. Approximately, 80% of meningiomas are classified by the World Health Organization (WHO) as grade I, and 20% of these tumors are grade II and III, considered high-grade meningiomas (HGMs). Clinical control of HGMs, as well as meningiomas that relapse after surgery, and ra...

Alternative Titles

Full title

Emerging Medical Treatments for Meningioma in the Molecular Era

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ae69b31270eb455eb0dae3caaa691ed6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ae69b31270eb455eb0dae3caaa691ed6

Other Identifiers

ISSN

2227-9059

E-ISSN

2227-9059

DOI

10.3390/biomedicines6030086

How to access this item